|KOMISJA NADZORU FINANSOWEGO|
|Raport bieżący nr||18||/||2021|
|Skrócona nazwa emitenta|
|The international expansion for CompuFlo Epidural Instrument with addition of three new distributors in Canada, Slovenia and United Arab Emirates and expanding commercial usage at leading hospital in Germany|
|Art. 17 ust. 1 MAR - informacje poufne.|
| The Board of Directors of Milestone Medical Inc. (WAR: MMD, “the Company", “the Issuer"), today announced that it has added three new international distributors for the CompuFlo Epidural Instrument, including Andau Medical in Canada, Sanolabor DD in Slovenia and New Al Farwaniya Surgicals and Medical Equipment LLC in the United Arab Emirates.
Andau Medical is a Medical Device and Dental Device company focused on providing the market with quality technologies that improve patient outcomes and enhance the clinical experience in delivering exceptional patient care. Andau has expertise in sales, marketing, regulatory and distribution of medical and dental devices.
Sanolabor is the largest Slovenian company for wholesale and marketing of medical devices, medical and hospital equipment and consumables, equipment for laboratories, medicines, personal protection products and dental products.
New Al Farwaniya was founded in 1981 with the strategy to service the medical sector in Abu Dhabi and Dubai, and has since become one of the oldest and largest distributors/suppliers in the health care sector in United Arab Emirates.
The Board of Directors of the Company is very pleased to have expanded the network with these distributors in key global markets and believes that each of them brings extensive relationships and a proven track record of introducing medical devices to their respective markets. In the opinion of the Board of Directors of the Issuer the global network the Company is developing demonstrates the interest and growing demand for the CompuFlo Epidural Instrument. Board of Directors of the Company believes that Andau Medical, Sanolabor and New Al Farwaniya are important additions, and assist in further adoption of our Epidural Instrument.
Additionally, The Board of Directors of the Issuer announced that the Company has witnessed increased usage of CompuFlo Epidural Instrument at the University Hospital of Würzburg, a leading national hospital and medical teaching institute in Germany, which provides a strong case study for further expansion activities in Europe. The Board of Directors of the Company believes this also illustrates the positive response among physicians as they increase utilization of the CompuFlo Epidural Instrument within their practice. The Board of Directors of the Company is looking forward to advancing the commercialization efforts around the world, as the Company’s aim is to establish the CompuFlo Epidural Instrument as the new standard of care during labor that is both safe, and with a decreased risk of side effects.
|MESSAGE (ENGLISH VERSION)|
|PODPISY OSÓB REPREZENTUJĄCYCH SPÓŁKĘ|
|Data||Imię i Nazwisko||Stanowisko/Funkcja||Podpis|
|2021-10-14||Keisha Harcum||Controller||Keisha Harcum|